<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="marinedrugs-17-00373-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">marinedrugs-17-00373-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Anti-influenza drugs.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Direct Acting Antiviral Drugs</th>
    <th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action of Antiviral Drugs</th>
    <th align="left" valign="top" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Side Effects</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Oseltamivir (Tamiflu)</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Competitive and selective inhibitor of neuraminidase of influenza viruses A and B</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">The gastrointestinal tract can be involved (nausea and vomiting; diarrhea, abdominal bloating, and fecal incontinence); central nervous system (dizziness, migraine, sleep disturbance, weakness); respiratory tract system (bronchitis, cough, infections of the upper respiratory tract); generalized pain</td>
   </tr>
   <tr>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Zanamivir (Relenza)</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Selective inhibitor of neuraminidase of influenza viruses A, inhibitor of replication and release of new virus particles</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Allergies, breathing problems, dermatological disorders</td>
   </tr>
   <tr>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Umifenovir (Arbidol)</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">A specific inhibitor of the fusion of a viral lipid membrane with cell membranes. Interacts with NA, prevents its conformation, which is necessary for the fusion of NA with endosome membranes. Interferon inductor. Stimulator of humoral and cellular immunity</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Pruritus, rash, angioedema, urticaria, anaphylaxis</td>
   </tr>
   <tr>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Riamylovir (Triazavirin)</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitor of viral RNA synthesis and replication of genomic fragments</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Allergies; the gastrointestinal tract can be involved (nausea and vomiting; diarrhea, abdominal bloating, and fecal incontinence)</td>
   </tr>
   <tr>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">Rimantadine, amantadine</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">M2 channel blockers. An inhibitor of the early stage of virus reproduction from the moment it enters the cell until the beginning of the transcription process. RNA inhibitor</td>
    <td align="left" valign="top" style="border-bottom:solid thin" rowspan="1" colspan="1">The gastrointestinal tract can be involved (diarrhea); central nervous system (dizziness, migraine, sleep disturbance, weakness); respiratory tract system (cough); generalized pain; allergies</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
